Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 388-393

  Tallant, E Ann ^a   Lu, Xiaowei ^a   Weiss, Randi B ^a   Chappell, Mark C ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin II; angiotensin receptor subtypes; angiotensin (1 7); endothelium; vascular

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN II [1-7]AMIDE[1 SARCOSINE]; ANGIOTENSIN RECEPTOR; LOSARTAN; RECEPTOR SUBTYPE;

ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM;

EID: 85026150685     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.388     Document Type: Article

References (47)

1. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin-(1-7): a member of circulating angiotensin peptides. Hypertension. 1991;17:131-138.
2. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1279.
3. Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 1996; 14:799-805.
4. Campbell DJ, Kladis A, Duncan A-M. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22: 513-522.
5. Lawrence AC, Evin G, Kladis A, Campbell DJ. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens. 1990;8:715-724.
6. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
7. Santos RAS, Brosnihan KB, Jacobsen DW, DiCorleto P, Ferrario CM. Production of Ang-(1-7) by human vascular endothelium. Hypertension. 1992;19(suppl II):II-56-II-61.
8. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma X glioma hybrid cell line. Peptides. 1990;22:375-380.
9. Santos RA, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, Ferrario CM. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension. 1988;11(suppl I): I-53-I-57.
10. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension. 1992;19:692-696.
11. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensm-(1-7) by thimet oligopeptidase (E.C.3.4.24.15) in vascular smooth muscle cells. J Vasc Biol Med. 1995;5:129-137.
12. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991:18(suppl III):III-126-III-133.
13. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrano CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA. 1988;85:4095-4098.
14. Ambuhl P, Felix D, Imboden H, Khosla MC, Ferrario CM. Effects of angiotensin analogs and angiotensin receptor antagonists on paraventricular neurons. Regul Pept. 1992;38:10-120.
15. Tallant EA, Jaiswal N, Diz DI, Ferrario CM. Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension. 1991;18:32-39.
16. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991;17:1115-1120.
17. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993;21:900-905.
18. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM. Differential regulation of prostaelandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther. 1993;265:664-673.
19. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrano CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides: characterization of receptors. Hypertension. 1992;19(suppl II):II-49-II-55.
20. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269:H313-H319.
21. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
22. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523-528.
23. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 1993;24:2041-2045.
24. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 1993; 234:35-42.
25. Nakamoto H, Ferrario CM, Fuller SB, Robaczwskj DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
26. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:104-108.
27. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7) Peptides. 1993;14:679-684.
28. Cocks TM, Angus JA, Campbell JH, Campbell GR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol. 1985;123:310-320.
29. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem. 1951;193:265-275.
30. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem. 1989;264:16518-16521.
31. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
32. Kambayash Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
33. Tsuzuki S, Ichiki T, Nakakubo H, Kitami Y, Guo D-F, Shirai H, Inagami T. Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem Biophys Res Commun. 1994;200:1449-1454.
34. Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MAP, Silva LCS, Neves LAA, Oliveira DR, Caligiorne SM, Rodngues ARV, Gropen C Jr, Carvalho WS, Silva ACSE, Khosla MC. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994;35:293-298.
35. Laredo J, Hamilton BP, Shah JR, Hamlyn JM. Angiotensin type-2 receptor mediates the secretion of endogenous ouabain from bovine adrenocortical cells. Hypertension. 1996;28:511. Abstract.
36. Quali R, Poulette S, Penhoat A, Saez JM. Characterization and coupling of angiotensin-II receptor subtypes in cultured bovine adrenal fasciculata cells. J Steroid Biochem Mol Biol. 1992;43:271-280.
37. Diz DI, Ferrario CM. Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1-7). In: Raizada MK, Phillips MI, Sumners C, eds. Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors. New York, NY: Plenum Press; 1996:225-235.
38. Diz DI, Bosch SM, Ferrario CM. High affinity angiotensin-(1-7) binding sites in the rat brain, pituitary and adrenal. FASEB J. 1992;6:A1165. Abstract.
39. Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension. 1991;17:1135-1143.
40. Chappell MC, Jacobsen DW, Tallant EA. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides. 1995;16:741-747.
41. Bernier SG, Servant G, Boudreau M, Fournier A, Guillemette G. Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. Eur J Pharmacol. 1995;291:191-200.
42. Neub M, Regitz-Zagrosek V, Hildebrandt A, Fleck E. Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation. Biochem Biophys Res Commun. 1994;204:1334-1339.
43. Ernsberger P, Zhou J, Damon TH, Douglas JG. Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol. 1992;263:F411-F416.
44. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest. 1995;95:995-1001.
45. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
46. Chappell MC, Diz DI, Ferrario CM. Urinary angiotensin-(1-7): influence of converting enzyme and neprilysin inhibition. Hypertension. 1995;26:542. Abstract.
47. Ferrario CM, Martell N, Pinillas C, Yunis C, Brosnihan KB, Chappell MC, Novikov S, Perez D, Flack JM, Luque M. Essential hypertension is associated with low urinary levels of angiotensin-(1-7). Hypertension. 1996;28:515. Abstract.